20.06.2018 • NewsDow ChemicalElaine Burridge

Dow Chemical Expands Glycol Ethers/Alkoxylates

Dow Chemical Expands Glycol Ethers/Alkoxylates
Dow Chemical Expands Glycol Ethers/Alkoxylates

Dow Chemical, part of the merged DowDuPont group, has announced plans to increase capacity for glycol ethers and alkoxylates to meet rising demand.

With regard to glycol ethers, a series of phased incremental investments will eventually double global output of Dow’s select p-series and performance product lines, including Dowanol. Starting in 2018, seven debottlenecking and expansion projects will take place over the next several years, with the first incremental capacity becoming available by the end of 2019. Details on site locations and capacities were not disclosed.

Glycol ethers are used to improve the performance and reduce the health and environmental impacts of end products in various applications. According to Dow, demand for glycol ethers continues to rise as a result of urbanization, a growing middle class, evolving and stricter regulations and increasing sustainability challenges.

The company will also invest in an alkoxylation facility at an undisclosed location on the US Gulf Coast. Start-up is expected by the end of 2021. Dow said the new capacity will support global growth in its core end-markets of infrastructure and home and personal care, along with strengthening market position for brands such as Triton,Tergitol and Ecsorf surfactants and Carbowax Sentry excipients/APIs.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.